Drug development costs putting pressure on ‘the whole innovative medicine model,’ says analyst 11-Dec-2018 By Melissa Fassbender Potentially increasing costs and dropping returns from investing in innovative medicines and devices will be among the main challenges faced in 2019, says industry analyst.